Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | SHBG | P04278 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 7/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5185800 | 0.82 | TP53 (0.47) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL175125 | 0.79 | TP53 (0.41) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL12321734 | 0.79 | TP53 (0.41) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL21155241 | 0.77 | TP53 (0.38) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL170961 | 0.77 | SHBG (0.39) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL12321190 | 0.76 | TP53 (0.43) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL12321238 | 0.76 | TP53 (0.43) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL12321179 | 0.76 | TP53 (0.43) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL26105785 | 0.74 | SHBG (0.42) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL5541917 | 0.73 | SHBG (0.41) | TP53KDM4EGMNNLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1921129-B1 | PERFUME COMPOSITION | KAO CORP (JP) | 2014-03-12 | — | — | EP | disclosed |
| US-7902142-B2 | Fragrance composition | KAO CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| EP-1555261-B1 | VALEROLACTONE COMPOUNDS AND PERFUME COMPOSITION | KAO CORP (JP) | 2010-09-01 | — | — | EP | disclosed |
| US-20090123404-A1 | FRAGRANCE COMPOSITION | KAO CORPORATION (JP) | 2009-05-14 | — | — | US | disclosed |
| US-7491833-B2 | Valerolactone compounds and perfume composition | KAO CORPORATION (JP) | 2009-02-17 | — | — | US | disclosed |
| EP-1921129-A1 | PERFUME COMPOSITION | Kao Corporation (JP) | 2008-05-14 | — | — | EP | disclosed |
| US-20060258559-A1 | Valerolactone compounds and perfume composition | KAO CORPORATION (JP) | 2006-11-16 | — | — | US | disclosed |
| EP-1555261-A1 | VALEROLACTONE COMPOUNDS AND PERFUME COMPOSITION | Kao Corporation (JP) | 2005-07-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090123404-A1 | FRAGRANCE COMPOSITION | NAA40, FAAH, TAS1R1 | TP53 3393/4885KDM4E 2048/4885GMNN 3392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.